Bioage Labs, Inc. · NASDAQ:BIOA
Goldstein Dov A Md exercised options for 3,542 Bioage Labs, Inc. shares (Form 4)
Traded Apr 23, 2026 · Filed Apr 24, 2026
On Apr 23, 2026, Goldstein Dov A Md (Chief Financial Officer) exercised options for 3,542 Bioage Labs, Inc. shares at US$4.38 for US$15,514, leaving 36,575 shares. Filed Apr 24, 2026 (Form 4).
- Options exercised
- 3,542 shares
- Price
- US$4.38
- Value
- US$15,514
- Holding after
- 36,575 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Common Stock | Option exercise | 3,542 | US$4.38 | 36,575 | Direct |
Source
Related
- Bioage Labs, Inc.
- Goldstein Dov A Md
- Bioage Labs, Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Form 4 · Barton Shane · Jul 1, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · May 15, 2026
- Schedule 13G/A · VK Services, LLC · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026